[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO992532L - Heptapeptid oksytocinanaloger - Google Patents

Heptapeptid oksytocinanaloger

Info

Publication number
NO992532L
NO992532L NO992532A NO992532A NO992532L NO 992532 L NO992532 L NO 992532L NO 992532 A NO992532 A NO 992532A NO 992532 A NO992532 A NO 992532A NO 992532 L NO992532 L NO 992532L
Authority
NO
Norway
Prior art keywords
oxytocin analogs
heptapeptide
heptapeptide oxytocin
analogs
oxytocin
Prior art date
Application number
NO992532A
Other languages
English (en)
Other versions
NO992532D0 (no
NO321380B1 (no
Inventor
Per Melin
Anders Nilsson
Jerzy Trojnar
Carl-Johan Aurell
Pierre Riviere
Robert Haig
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO992532L publication Critical patent/NO992532L/no
Publication of NO992532D0 publication Critical patent/NO992532D0/no
Publication of NO321380B1 publication Critical patent/NO321380B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO19992532A 1996-11-26 1999-05-26 Heptapeptid analog med oksytocinantagonistaktivitet, fremgangsmate ved fremstilling derav samt anvendelse derav til fremstilling av medikamenter. NO321380B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9604341A SE9604341D0 (sv) 1996-11-26 1996-11-26 Hepta-peptide oxytocin analogue
PCT/SE1997/001968 WO1998023636A1 (en) 1996-11-26 1997-11-21 Heptapeptide oxytocin analogues

Publications (3)

Publication Number Publication Date
NO992532L true NO992532L (no) 1999-05-26
NO992532D0 NO992532D0 (no) 1999-05-26
NO321380B1 NO321380B1 (no) 2006-05-02

Family

ID=20404757

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992532A NO321380B1 (no) 1996-11-26 1999-05-26 Heptapeptid analog med oksytocinantagonistaktivitet, fremgangsmate ved fremstilling derav samt anvendelse derav til fremstilling av medikamenter.

Country Status (35)

Country Link
US (1) US6143722A (no)
EP (1) EP0938496B1 (no)
JP (1) JP3405460B2 (no)
KR (1) KR100463132B1 (no)
CN (1) CN1129606C (no)
AR (1) AR008531A1 (no)
AT (1) ATE242264T1 (no)
AU (1) AU713424B2 (no)
BR (1) BR9713366B1 (no)
CA (1) CA2272990C (no)
CZ (1) CZ299532B6 (no)
DE (1) DE69722651T2 (no)
DK (1) DK0938496T3 (no)
EE (1) EE03832B1 (no)
ES (1) ES2203823T3 (no)
HK (1) HK1022481A1 (no)
HR (1) HRP970630B1 (no)
HU (1) HU228568B1 (no)
IL (1) IL129519A (no)
LT (1) LT4650B (no)
LV (1) LV12350B (no)
MY (1) MY125555A (no)
NO (1) NO321380B1 (no)
NZ (1) NZ336445A (no)
PL (1) PL189292B1 (no)
PT (1) PT938496E (no)
RO (1) RO120772B1 (no)
RU (1) RU2180668C2 (no)
SE (1) SE9604341D0 (no)
SI (1) SI20026B (no)
SK (1) SK283800B6 (no)
TR (1) TR199901028T2 (no)
UA (1) UA54459C2 (no)
WO (1) WO1998023636A1 (no)
ZA (1) ZA9710518B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
US6476072B1 (en) * 2000-11-21 2002-11-05 Arthur Vanmoor Method of treating menstrual pain by enhancing the effectiveness of the human immune system
JP4615221B2 (ja) * 2002-02-27 2011-01-19 フェリング ベスローテン フェンノートシャップ ヘプタペプチドオキシトシンアナログを製造するための中間体及び方法
EP1504268A2 (en) * 2002-05-02 2005-02-09 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
UA76639C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
EP1530967B1 (en) * 2003-11-13 2006-05-03 Ferring B.V. Blister pack and solid dosage form comprising desmopressin
EP1555029A1 (en) 2004-01-19 2005-07-20 Ferring B.V. Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension
US20060171909A1 (en) * 2005-02-03 2006-08-03 The Procter & Gamble Company Cosmetic compositions comprising colorants with low free dye
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
JP5451613B2 (ja) 2007-08-06 2014-03-26 アラーガン、インコーポレイテッド デスモプレシン薬物送達のための方法及びデバイス
BRPI0910345B1 (pt) * 2008-03-31 2021-08-17 Ferring B.V. Compostos análogos de oxitocina, composição farmacêutica compreendendo os mesmos e uso dos ditos análogos
PT3225249T (pt) 2008-05-21 2019-01-17 Ferring Bv Desmopressina orodispersível para aumentar o período inicial de sono não perturbado pela nocturia
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
TWI463990B (zh) * 2009-09-21 2014-12-11 Ferring Bv 催產素受體促進劑
MX2013000543A (es) 2010-07-15 2013-10-28 Oleg Iliich Epshtein Un metodo para aumentar el efecto de una forma activa potenciada de un anticuerpo.
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
JP6150726B2 (ja) 2011-03-09 2017-06-21 Jitsubo株式会社 新規な非ペプチド性架橋構造を含む架橋ペプチド、ならびに該架橋ペプチドの合成方法および該方法に用いる新規な有機化合物
CN102875650B (zh) * 2012-09-26 2014-06-11 深圳翰宇药业股份有限公司 巴卢西班的制备方法
US9365615B2 (en) 2013-09-09 2016-06-14 Jitsubo Co., Ltd. Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
EP3501533A1 (en) 2014-12-22 2019-06-26 Ferring B.V. Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
CA3001057A1 (en) 2015-10-06 2017-04-13 Ferring B.V. New methods for making barusiban and its intermediates
PL3400217T3 (pl) 2016-01-04 2022-07-04 Merck Serono S.A. L-walinian pochodnej hydroksypropylotiazolidynokarboksyamidu, jego sól i postać krystaliczna
SG11201900461UA (en) 2016-07-21 2019-02-27 ObsEva SA Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
AU2020340670A1 (en) 2019-09-03 2022-04-07 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
US20230102503A1 (en) 2020-02-10 2023-03-30 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2036973A1 (en) * 1990-02-27 1991-08-28 Mark G. Bock Cyclic hexapeptide oxytocin antagonists
SE9002384D0 (sv) * 1990-07-09 1990-07-09 Ferring Ab Derivat av baklobshormoner
SE501678C2 (sv) * 1993-07-13 1995-04-10 Ferring Bv Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
SE523819C2 (sv) 1994-01-27 2004-05-18 Per-Ingvar Nilsson Accelerationsmunstycke samt metod för dess användning
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
SE9500249L (sv) 1995-01-25 1996-03-25 Valeo Engine Cooling Ab Värmeväxlartank med ändstycken, förfarande för framställning av en sådan tank, samt värmeväxlare försedd med en sådan

Also Published As

Publication number Publication date
CN1129606C (zh) 2003-12-03
EE9900210A (et) 1999-12-15
SK283800B6 (sk) 2004-02-03
WO1998023636A1 (en) 1998-06-04
TR199901028T2 (xx) 1999-07-21
JP2000507617A (ja) 2000-06-20
DE69722651D1 (en) 2003-07-10
HRP970630B1 (en) 2002-04-30
BR9713366B1 (pt) 2010-05-18
LV12350A (lv) 1999-09-20
EP0938496A1 (en) 1999-09-01
LV12350B (en) 1999-11-20
KR20000069045A (ko) 2000-11-25
AR008531A1 (es) 2000-01-19
US6143722A (en) 2000-11-07
IL129519A0 (en) 2000-02-29
AU5142998A (en) 1998-06-22
CZ299532B6 (cs) 2008-08-27
LT99052A (en) 2000-01-25
SK70499A3 (en) 2000-10-09
HUP0000577A2 (hu) 2000-11-28
RU2180668C2 (ru) 2002-03-20
SI20026B (sl) 2000-06-30
HK1022481A1 (en) 2000-08-11
ZA9710518B (en) 1998-06-10
BR9713366A (pt) 2000-01-25
ES2203823T3 (es) 2004-04-16
NO992532D0 (no) 1999-05-26
PT938496E (pt) 2003-10-31
SE9604341D0 (sv) 1996-11-26
AU713424B2 (en) 1999-12-02
CA2272990C (en) 2002-11-19
JP3405460B2 (ja) 2003-05-12
UA54459C2 (uk) 2003-03-17
NZ336445A (en) 2000-06-23
NO321380B1 (no) 2006-05-02
LT4650B (lt) 2000-04-25
RO120772B1 (ro) 2006-07-28
ATE242264T1 (de) 2003-06-15
EP0938496B1 (en) 2003-06-04
SI20026A (sl) 2000-02-29
HUP0000577A3 (en) 2001-02-28
DK0938496T3 (da) 2003-10-06
HU228568B1 (en) 2013-04-29
CZ183299A3 (cs) 2000-05-17
CN1238781A (zh) 1999-12-15
CA2272990A1 (en) 1998-06-04
DE69722651T2 (de) 2004-04-08
HRP970630A2 (en) 1998-10-31
PL189292B1 (pl) 2005-07-29
KR100463132B1 (ko) 2004-12-23
MY125555A (en) 2006-08-30
EE03832B1 (et) 2002-08-15
IL129519A (en) 2004-09-27

Similar Documents

Publication Publication Date Title
DK0938496T3 (da) Heptapeptidoxytocinanaloger
NO983069D0 (no) Inhalasjonsanordning
DK1042359T3 (da) k-Opioidreceptorpeptider
DE69625739D1 (de) Schlauchaufbau enthaltend Fluorterpolymere
DE59707564D1 (de) Fungizide mischung
FI102731B (fi) Näyteputki
FR2747926B1 (fr) Inhalateurs ameliores
ID19474A (id) Turunan tiazola
NO985680D0 (no) Peptidderivater
ID18095A (id) Turunan tetrahidrokinolin
DE19581877T1 (de) Verbesserter Kreiselbrecher
NO983849L (no) Peptidderivater
FI970168A0 (fi) Peptidejä
DE59806407D1 (de) Drucktaster
DE69819097D1 (de) Drucktaster
DE59801799D1 (de) Reinigungsgerät
DE59706870D1 (de) Fungizide mischung
DE59803807D1 (de) Reinigungsgerät
DK1137667T3 (da) GLP-1-analoger
DE69715327D1 (de) Reinigungsgerät
FI950211A0 (fi) Huokosia muodostavia peptidejä Geolycosa riograndesta
DE19882184T1 (de) Cyclosporin enthaltende Präparation
DE59811930D1 (de) Drucktaster
KR950024252U (ko) 부착이 용이한 단추
KR970056542U (ko) 넥타이

Legal Events

Date Code Title Description
MK1K Patent expired